This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (571)

Published on in Vol 6, No 7 (2017): July

Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study

Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study

Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study

Authors of this article:

Rosa T van der Kaaij1 Author Orcid Image ;   Hidde JW Braam2 Author Orcid Image ;   Henk Boot3 Author Orcid Image ;   Maartje Los4 Author Orcid Image ;   Annemieke Cats3 Author Orcid Image ;   Cecile Grootscholten5 Author Orcid Image ;   Jan HM Schellens6 Author Orcid Image ;   Arend GJ Aalbers1 Author Orcid Image ;   Alwin DR Huitema7, 8 Author Orcid Image ;   Catherijne AJ Knibbe9 Author Orcid Image ;   Djamila Boerma2 Author Orcid Image ;   Marinus J Wiezer2 Author Orcid Image ;   Bert van Ramshorst2 Author Orcid Image ;   Johanna W van Sandick1 Author Orcid Image
Article Authors Cited by (16) Tweetations (5) Metrics

Journals

  1. Brenkman H, Gertsen E, Vegt E, van Hillegersberg R, van Berge Henegouwen M, Gisbertz S, Luyer M, Nieuwenhuijzen G, van Lanschot J, Lagarde S, de Steur W, Hartgrink H, Stoot J, Hulsewe K, Spillenaar Bilgen E, van Det M, Kouwenhoven E, van der Peet D, Daams F, van Sandick J, van Grieken N, Heisterkamp J, van Etten B, Haveman J, Pierie J, Jonker F, Thijssen A, Belt E, van Duijvendijk P, Wassenaar E, van Laarhoven H, Wessels F, Haj Mohammad N, van Stel H, Frederix G, Siersema P, Ruurda J. Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study). BMC Cancer 2018;18(1) View
  2. Kodera Y. Surgery with curative intent for stage IV gastric cancer: Is it a reality of illusion?. Annals of Gastroenterological Surgery 2018;2(5):339 View
  3. Paredes A, Guzman-Pruneda F, Abdel-Misih S, Hays J, Dillhoff M, Pawlik T, Cloyd J. Perioperative Morbidity of Gastrectomy During CRS-HIPEC: An ACS-NSQIP Analysis. Journal of Surgical Research 2019;241:31 View
  4. BARCHI L, RAMOS M, DIAS A, YAGI O, RIBEIRO-JÚNIOR U, ZILBERSTEIN B, CECCONELLO I. TOTAL OMENTECTOMY IN GASTRIC CANCER SURGERY: IS IT ALWAYS NECESSARY?. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2019;32(1) View
  5. Koemans W, van der Kaaij R, Boot H, Buffart T, Veenhof A, Hartemink K, Grootscholten C, Snaebjornsson P, Retel V, van Tinteren H, Vanhoutvin S, van der Noort V, Houwink A, Hahn C, Huitema A, Lahaye M, Los M, van den Barselaar P, Imhof O, Aalbers A, van Dam G, van Etten B, Wijnhoven B, Luyer M, Boerma D, van Sandick J. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II). BMC Cancer 2019;19(1) View
  6. Zhao B, Mei D, Zhang J, Zou S, Lu H, Xu H, Huang B. The prognostic significance of macroscopic serosal change in subserosal invasion (stage T3) gastric cancer. The Annals of The Royal College of Surgeons of England 2019;101(4):249 View
  7. Koemans W, van der Kaaij R, Wassenaar E, Grootscholten C, Boot H, Boerma D, Los M, Imhof O, Schellens J, Rosing H, Huitema A, van Sandick J. Systemic exposure of oxaliplatin and docetaxel in gastric cancer patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy. European Journal of Surgical Oncology 2021;47(2):486 View
  8. Kaaij R, Wassenaar E, Koemans W, Sikorska K, Grootscholten C, Los M, Huitema A, Schellens J, Veenhof A, Hartemink K, Aalbers A, Ramshorst B, Boerma D, Boot H, Sandick J. Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results. British Journal of Surgery 2020;107(11):1520 View
  9. Koemans W, Houwink A, van der Kaaij R, Wassenaar E, Boerma D, Hahn C, Imhof O, Brandt M, Ariëns M, Veenhof A, Hartemink K, van Sandick J. Perioperative Management of Gastric Cancer Patients Treated With (Sub)Total Gastrectomy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Lessons Learned. Annals of Surgical Oncology 2021;28(8):4647 View
  10. Koemans W, van der Kaaij R, Wassenaar E, Boerma D, Boot H, Sikorska K, Los M, Grootscholten C, Hartemink K, Veenhof A, Kodach L, Snaebjornsson P, van Sandick J. Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial. Journal of Surgical Oncology 2021;123(4):904 View
  11. Polkowski W, Rawicz-Pruszynski K, Mielko J, Geca K, Skorzewska M, Cisel B. Treatment of peritoneal metastases from gastric carcinoma. Current Issues in Pharmacy and Medical Sciences 2017;30(4):173 View
  12. Gantsev S, Gantsev K, Kzyrgalin S, Ishmuratova K. Peritoneal Canceromatosis in Malignant Tumors of Various Localizations. Achievements and Prospects. Creative surgery and oncology 2021;11(2):149 View
  13. Sammartino P, De Manzoni G, Marano L, Marrelli D, Biacchi D, Sommariva A, Scaringi S, Federici O, Guaglio M, Angrisani M, Cardi M, Fassari A, Casella F, Graziosi L, Roviello F. Gastric Cancer (GC) with Peritoneal Metastases (PMs): An Overview of Italian PSM Oncoteam Evidence and Study Purposes. Cancers 2023;15(12):3137 View
  14. Gingrich A, Manguso N, Zuckerman R. Treatment of Gastric Cancer Carcinomatosis. Surgical Clinics of North America 2025;105(1):95 View

Books/Policy Documents

  1. Bogach J, McCart A, Bischof D, Govindarajan A. Surgical Oncology Manual. View
  2. Ray M. Multidisciplinary Approach to Surgical Oncology Patients. View